From left Frode Jahren (Secretary General of LHL), Frode Gallefoss and John Normann Melheim (Chairman of the LHL). Photo: Mari Larsen (Ass. Secretary General in LHL).

Professor at Department of Clinical Science, University of Bergen, and Research Manager at Sørlandet Hospital, Frode Gallefoss, was on 15 November 2017 awarded by the National Association for Heart and Lung Diseases’ (LHL’s) chairman, John Normann Melheim, for outstanding scientific work in chronic obstructive pulmonary disease (COPD). The price is NOK 50,000. Frode Gallefoss is an international researcher who has developed better prevention, patient training and treatment of people with COPD. Epochal was his innovative utility-cost studies of patient education programs. Earlier, he has received the WHO’s Gold Medal for International Anti-Tobacco Work and the Quality Assurance Prize of the Norwegian Medical Association.

K2 congratulates!

(The review is an excerpt from the committee’s recommendation.)